Search

Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.”   The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.

Read More About Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

Only hospital in northern Nevada to receive national recognition for patient safety and quality Renown South Meadows Medical Center in south Reno has earned an “A” Hospital Safety Grade from The Leapfrog Group, a nonprofit watchdog organization that serves as a voice for health care consumers and purchasers, using their collective influence to foster positive change in U.S. health care. Leapfrog is the nation’s premier advocate of transparency in health care—collecting, analyzing, and disseminating data to inform value-based purchasing and improved decision-making. This national distinction recognizes Renown Health’s national accomplishments in ensuring safe, high-quality hospital care for patients. The Leapfrog Group is an independent, nonprofit organization that upholds the standard of patient safety in hospitals and ambulatory surgery centers. Developed under the guidance of a national expert panel, the Leapfrog Hospital Safety Grade uses publicly available hospital safety data to assign grades to more than 2,700 U.S. acute-care hospitals twice per year. Leapfrog assigns an “A,” “B,” “C,” “D” or “F” grade to general hospitals across the country based on over 30 measures of errors, accidents, injuries, and infections as well as the systems hospitals have in place to prevent them.  Leapfrog sets their standards using peer reviewed literature and expert opinion, peer comparisons, and alignment with existing national standards or performance targets. “We are very proud to recognize physicians, nurses, clinicians and the entire team at Renown South Meadows Medical Center for achieving exceptional Leapfrog performance in Patient-Centered Care, Critical Care, Nursing and Bedside Care for Patients, Patient Safety, Medication Safety, and Care for Total Joint Replacement and Elective Outpatient Surgery Patients,” said Brian Erling, MD, MBA, President and CEO, Renown Health. “As the only locally governed not-for-profit academic healthcare network in the region, Renown’s success is shared with our patients and community. We celebrate and thank our physicians, nurses, and caregivers for their continued dedication to making a genuine difference in the health and well-being of the people and communities we serve.” “Everyone who works at Renown South Meadows Medical Center should be proud of this ‘A’ Hospital Safety Grade,” said Leah Binder, president, and CEO of The Leapfrog Group. “It takes complete dedication at every level, and an ironclad commitment to putting patients first. I thank Renown South Meadows Medical Center’s leadership, clinicians, staff, and volunteers for caring so deeply for patients and their safety.” “We are proud of our affiliated physicians and teams who give their best every day, to ensure that every patient’s care and safety is their top priority,” said Sam Weller, MHPA, CEO, Renown South Meadows Medical Center. “We recognize that when you choose a hospital, you could be making a life-or-death decision. Not every hospital is the same. Performance on things like infection rates, surgical errors, or patient injuries varies considerably—and matters greatly. It’s important for consumers to know and consider these things when choosing what physicians, hospital, or Emergency Room to select for their care. We are very excited to be recognized as the only hospital to achieve this designation in northern Nevada, and only one of two in the state (the other being in Las Vegas).”   To see Renown South Meadows Medical Center’s full grade details and to access patient tips for staying safe in the hospital, visit HospitalSafetyGrade.org and follow The Leapfrog Group on Facebook, LinkedIn, Instagram and X (formerly Twitter) and via The Leapfrog Group newsletter.   The Hospital Safety Grade’s methodology is peer-reviewed and fully transparent, and the results are free to the public. Renown Regional Medical Center received a B score for Fall & Spring 2023. For more information on the Leapfrog Group and the Spring 2023 scores, please visit: hospitalsafetyscore.org. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated health care network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,400 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. For more information, visit renown.org.  About The Leapfrog Group Founded in 2000 by large employers and other purchasers, The Leapfrog Group is a national nonprofit organization driving a movement for giant leaps for patient safety. The flagship Leapfrog Hospital Survey and Leapfrog Ambulatory Surgery Center (ASC) Survey collect and transparently report hospital and ASC performance, empowering purchasers to find the highest-value care and giving consumers the lifesaving information they need to make informed decisions. The Leapfrog Hospital Safety Grade, Leapfrog's other main initiative, assigns letter grades to hospitals based on their record of patient safety, helping consumers protect themselves and their families from errors, injuries, accidents and infections. For more, follow us on Twitter, Facebook, LinkedIn and Instagram and sign up for our newsletter.

Read More About Renown South Meadows Medical Center Earns Highest "A" Hospital Safety Grade from The Leapfrog Group

Gilead Sciences, Inc. (Nasdaq: GILD) and the Renown Institute for Health Innovation (IHI) today announced a strategic collaboration to collect and analyze genetic and electronic health data that can enhance the understanding of nonalcoholic steatohepatitis (NASH) and potentially inform development of treatment options for the disease. Under the terms of the collaboration and license agreement, Gilead will provide funding to Renown IHI to sequence and analyze the DNA of 15,000 individuals living with NASH or nonalcoholic fatty liver disease (NAFLD) as well as a control cohort of 40,000 individuals in Nevada. “Combining the sequencing of protein coding DNA, with extensive electronic health record data will enable a deep analysis of the roles of genetics and environment in NASH incidence and progression,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “The analysis of these large datasets in collaboration with Renown IHI could help identify genetic variants that impact the risk of developing NASH and thereby advance the discovery and development of new treatments for this disease.” Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has 40,000 participants. “Combining genetic sequencing with large sets of data can play a critical role in understanding and identifying serious health risks, including diseases like NASH. We are excited to collaborate with Gilead to better understand the condition and its complexities,” said Anthony Slonim, MD., DrPH. “Any genetic variants identified in participants through the collaboration may be shared with the participants for patient care purposes.”     About NASH Nonalcoholic steatohepatitis (NASH) is a chronic form of liver disease characterized by excess fat in the liver, inflammation, and liver cell damage. Inflammation and liver cell damage can cause scarring of the liver, or fibrosis, and ultimately lead to cirrhosis or liver cancer. NASH is more common in people with certain conditions, including obesity and type 2 diabetes. There are currently limited approved treatments for patients living with NASH.   About Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.   About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown Health’s commitment has extended beyond traditional health care to include community health and well-being. Renown Health works to improve health care through science, research and genetics; forge community partnerships that improve lives and develop innovative models that are improving health care in Nevada. For more information, visit renown.org.    About Helix Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Powered by their proprietary Exome+™ assay—a panel-grade exome enhanced by more than 300,000 informative non-coding regions—Helix offers health systems a scalable solution which enables the discovery of medically relevant, potentially life-saving, genetic information. Additionally, Helix offers a suite of DNA-powered products for continued individual engagement and discovery. Helix is headquartered in the San Francisco Bay Area and has one of the world’s largest CLIA-certified, CAP-accredited Next Generation Sequencing labs, located in San Diego, California. Learn more at www.helix.com. Helix, the Helix logo, and Exome+ are trademarks of Helix Opco, LLC.   Gilead Forward-Looking Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this collaboration, and Gilead may fail to discover, develop and commercialize any product candidates for the treatment of NASH. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, as filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.   Additional Media Contact: Sung Lee, Investors                                                                                                                                                        650-524-7792 Arran Attridge, Media                                                                                                                                                        650-425-8975

Read More About Gilead Sciences and Renown Institute for Health Innovation Announce Strategic Collaboration to Advance Understanding of Nonalcoholic Steatohepatitis (NASH)

The study could expand to a quarter million people, making Nevada the only state in the U.S. to offer such a program. Las Vegas, Nev. (May 2, 2019) – The Healthy Nevada Project, a first-of-its-kind, community-based population health study combining genetic, clinical, environmental and social data, is expanding enrollment to Las Vegas. The Project aspires not only to offer genetic testing to every Nevadan interested in learning more about their health and genetic profile but ultimately, to develop and expand the Project for communities across the United States to drive positive health outcomes nationwide.   Adding 25,000 Study Volunteers in Southern Nevada The Healthy Nevada Project is announcing a statewide expansion – opening 25,000 testing slots in Las Vegas. With southern Nevada welcoming the study, the Healthy Nevada Project will offer no-cost genetic testing through a simple spit sample to 25,000 study volunteers. Study volunteers will take Helix’s clinical-grade DNA saliva test and will receive their ancestry and traits, at no cost, through the My Healthy Nevada Traits app. Participants will then be given a chance to answer a follow-up health survey from Renown Institute for Health Innovation (Renown IHI), and upon survey completion, will be entered to win an iPhone. In addition, study participants can agree to be notified about genetic test results that could impact their health, and which could be used to improve their medical care. This return of clinical results, plus genetic counseling and other genetic services as appropriate, will be provided by Genome Medical, the leading network of clinical genetics specialists.   Healthy Nevada Project’s Evolution & Ongoing Expansion With more than 35,000 study participants enrolled in just over two years, the Healthy Nevada Project has become the fastest-enrolling genetic study in the country. The Project was created by Renown IHI – a collaboration between Reno, Nev.-based not-for-profit health network, Renown Health, and the world leader in environmental data, Desert Research Institute (DRI). Leveraging Renown’s forward-thinking approach to community health care and DRI’s data analytics and environmental expertise, Renown IHI has grown its capabilities to lead a larger, more complex research study of significance that will analyze and model public health risks in Nevada and serve as a national model for future population health studies working to improve overall health through clinical care integration. During the Project’s pilot launch in September 2016, more than 10,000 community members signed up for DNA testing in just 48 hours. In March 2018, phase two offered full genomic sequencing through a simple spit test from Helix to northern Nevadans. In October 2018, the Project announced the return of clinical results for study participants, notifying them of their risk for CDC Tier 1 conditions including familial hypercholesterolemia, BRCA positive 1 and 2, and Lynch syndrome, a precursor to colon cancer. These conditions affect more than one percent of the population and are inherited so they impact family members as well. Now, the Project announced its next phase – expanding enrollment to 25,000 people in southern Nevada.   Serving as a National Model This expansion to Las Vegas truly makes this the “Healthy Nevada Project” with a statewide impact making Nevada the only state in the U.S. to offer such a program. “Nevada was ripe to advance population health goals because, sadly, our state ranks near the bottom in health outcomes. The Healthy Nevada Project is working to change that,” said Anthony Slonim, M.D., DrPH, FACHE, president and CEO of Renown Health and president of Renown IHI. “Our researchers are working on a number of clinical programs and scientific studies to determine why in Washoe County, the county in which Renown Health is located, Nevada’s age-adjusted death rates for heart disease, cancer and chronic lower respiratory disease are 33 percent higher than the national rate. Imagine if we can gather more data like this on a national scale and use it to change the future of health and health care? That is what the Healthy USA Project is looking to do in the years to come.” “The Healthy Nevada Project is committed to providing study participants clinically actionable data that will help improve their health,” said Joseph Grzymski, Ph.D., associate research professor at DRI, principal investigator of the Healthy Nevada Project and chief scientific officer for Renown Health. “We are providing this information at the individual level so study volunteers can make lifesaving changes to reduce their risk. We’re also doing it on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country.”   Expanding to Become the Healthy USA Project The accelerated speed of the Project is made possible thanks to the ever-decreasing cost of sequencing. Today, Helix is able to sequence an entire exome – which allows reporting on most actionable genomic knowledge – for a fraction of what it would have cost just 10 years ago. Additionally, advances in digital health mean Helix and Project researchers can capture unprecedented amounts of health data digitally, making significant contributions to advancing precision health. The partnership has managed to remove the traditional barriers of population health studies, including the difficulty in recruiting participants, establishing quality high through put lab systems, and scaling interpretation and return of results. This development will be key as other health systems around the country join the Project. “We are thrilled to see the constant, fast-paced evolution of this Project with Renown IHI,” said Justin Kao, CoFounder of Helix. “In less than a year, we have sequenced the DNA of thousands of study participants and are now preparing to offer this incredible study in other states. Combining environmental, clinical, social and genetic data allows us to discover risk factors within communities and help people take action to live longer, healthier lives. That’s what makes the next step of the Healthy USA Project so exciting for all of us. ”Full details on study’s evolution and southern Nevada enrollment will be revealed at a press event in Las Vegas on Tuesday, May 7 at 3 p.m.     Renown Institute for Health Innovation  Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at https://healthynv.org/.  Helix is a genomics company with a simple but powerful mission: to empower every person to improve their life through DNA. Our affordable, turnkey population health solution enables institutions to quickly scale projects that engage communities and accelerate research and discovery, ultimately allowing every person to benefit from the power of genomics. We've also created the first marketplace for DNA-powered products where people can explore diverse and uniquely personalized products developed by high-quality partners, providing powerful tools to increase engagement and speed the pace of population-scale genomics. Helix is headquartered in the San Francisco Bay Area, has an office in Denver, Colorado and operates a CLIA-certified and CAP-accredited next-generation sequencing lab in San Diego powered by Illumina (NASDAQ: ILMN) NGS technology. Helix was created in 2015. Learn more at www.helix.com.  Helix, the Helix logo and Exome+ are trademarks of Helix Opco, LLC. All other trademarks referenced herein are the property of their respective owners.   Additional Media Contacts: Tracy Bower                                                                                                                                                                          DRI                                                                                                                                                                                      702-862-5404                                                                                                                                                      media@dri.edu Eric Schubert                                                                                                                                                                        Seismic for Helix                                                                                                                                                                    415-939-4366                                                                                                                                                    press@helix.com

Read More About Population Health Study Goes Statewide and Opens Enrollment

For leaders, employees and patients of Renown Health, April 14, 2020 will eternally be etched into the COVID-19 pandemic timeline. This was the day the organization invited community leaders and members of the media to tour the Alternate Care Site (ACS) in the Mill St. Parking structure. While other healthcare systems around the world were setting up field hospitals to care for an anticipated influx of COVID-19 patients, Renown was the first to do so in a parking garage. During this preview event, Renown Health CEO and President, Dr. Tony Slonim, spoke to area leaders on the decision to commission the $11 million Alternate Care Site, which at the time, was a precautionary measure and a demonstration of Renown’s commitment to the health and well-being of the one million people and communities it serves across 100,000 square miles of Nevada, Lake Tahoe and northeast California. Also on April 14, 2020, Dr. Slonim observed his 56th birthday. Rather than a celebration to mark the occasion, during the news conference, he received a call that would further alter his life. The intensivist caring for his dad, Anthony Slonim Sr., in a New Jersey hospital, told him that after a hard-fought battle against the novel coronavirus, his father had died. Dr. Slonim said, “April 14, 2020 was the day the COVID-19 pandemic was no longer just a tragedy devastating the east coast and other hotspots around the world. COVID-19 hit home, stealing my father and threating both of my beloved communities- New Jersey and Reno - that my family calls home.” The bright light of LOVE shines through the darkness Later that week, on April 16, 2020, Beth Macmillan, Executive Director of Artown loaned Renown the LOVE sculpture, a one-ton, welded aluminum artwork with letters 10-feet tall and eight-feet wide created by artist Laura Kimpton and fabricated by Jeff Schomberg, where it lights up Renown Regional Medical Center’s main entrance. LOVE glows, and continues to glow, in Renown’s signature purple every evening, shining brightly for patients, employees, visitors and passersby to enjoy. The art piece debuted at Burning Man in 2019, and was originally slated for the 9/11 Tribute Museum in NYC.  “Healthcare heroes and patients of the hospital have been warmed and inspired by the art and this one word, LOVE! Now, more than ever, the power of art has provided something beautiful on which to focus,” says Beth Macmillan. In July, the LOVE sculpture found a permanent home at Renown thanks to a donation from the Robert and Dorothy Keyser Foundation. “Through the height of the COVID-19 pandemic, the LOVE sculpture has been a powerful source of hope, inspiration and determination for our community,” said Blake Smith, chair of the Keyser Foundation. “Now, we can’t imagine the entrance of the hospital without it. We are happy that the incredible piece of art will continue shining a bright light while spreading warmth and comfort to all who care for those in our hospitals, patients and families, and those who pass by.” (LOVE sign B-Roll.) For Dr. Slonim, he found the art a reminder of the love of his father. “I have so much respect for artists like Laura and Jeff, and the way they connect with people through their art. Passing by the LOVE sculpture was immensely therapeutic for me, especially after the loss of my dad,” said Dr. Slonim. “Caring for others and their emotions is also an art. Over the last year, I have been inspired by the compassionate caregivers who have practiced the art of medicine under extremely stressful and difficult conditions brought on by the pandemic.” When words fail, art speaks Recognizing art’s powerful healing capabilities, Renown collaborated with prominent artist and fine art photographer, Anicia Beckwith, to immortalize the many battles fought against and amidst COVID-19 within the healthcare system’s walls. Beckwith captured portrait images of Renown caregivers, patients and their loved ones, showing raw and touching scenes from the COVID Intensive Care Unit, Emergency Departments, Neonatal Intensive Care Unit, Wilbur D. May Pediatric Intensive Care Unit and the Alternate Care Site field hospital. A group of Renown caregivers hold a COVID patient’s hand. Tears well up in their eyes as the patient takes his last breath. Care providers respond to a patient’s only request – a facial shave. The man beams at the sight of his freshly groomed face, and is visibly touched by the tender care he received to make it happen. Lupe, an environmental services worker, takes special care in her efforts to clean and sanitize patient rooms—a craft she has perfected and taken pride in for the 25+ years she’s worked at Renown. These are just a few of the captivating moments Beckwith illustrates through her art. Beckwith’s full photo gallery of images from Renown are located here; and downloadable visual assets are available here.    “I was in awe as I watched Renown caregivers administer chest compressions to a patient whose heart had just stopped,” said Beckwith. Promptly after assisting in saving that patient’s life, I observed a nurse walk into the room next door where an elderly patient peacefully discussed coming to the end of hers. I can’t help but wonder how the staff have these conversations daily—always with compassion, dignity and grace. It was an honor and privilege to commemorate this pivotal time in our world’s history, and in turn, aid in the healing process for those hurting both physically and emotionally.”  “Anicia’s photography provided a comforting outlet for all who were involved in the project,” said Annie Zucker, Manager of Community Impact at Renown. “Her work gave care givers an opportunity to reflect on the last year and fueled the strength and determination they needed to get through it, as sometimes it takes an outside lens to see the magnitude and impact of your work. Anicia gave patients and families an opportunity share their stories and feel support and encouragement from the outside world.” In addition to taking photos on standard digital cameras, Beckwith also honed her skills using various vintage film cameras and historical techniques. “I purposely use these images as testimony to the science in front and behind the lens,” said Beckwith. “COVID has shown us technological advances cannot cure every condition, and sometimes we must go back to the basics to move forward. Some of the film I used for this project is no longer made and rare to possess. Each time I click the shutter translates to one less photographic possibility left in the world. To decide when and what to capture is a metaphor for the importance, reverence and weight I place on the subject in front of me.” Beckwith plans to continue her photography project at Renown using a 104-year-old camera that was present during the time of the Spanish Flu of 1918. Her goal is to highlight the remarkable stories of strength, resilience and perseverance that have come from the ashes of the pandemic, as we look towards a hopeful future. “For more than 30 years, art has played an important role at Renown Health,” said Sy Johnson, Chief of Staff at Renown. “Healing is more than getting quality medical care—it’s about the heart, the mind and the spirit. We are proud to bring extraordinary artists like Laura Kimpton, Jeff Schomberg, Anicia Beckwith and others, to find meaningful ways to connect with our patients, employees and community through the universal language of healing arts. Much of the art on our campuses has been made possible by generous artists and donors, who have make a tremendous impact on how our community—and our providers—reflect, engage and heal.”  If you are interested in supporting the Healing Arts Program at Renown Health, a charitable, non-profit health organization, please consider giving to Renown Health Foundation.  Donations are accepted through the following ways: Make a gift at www.renown.org/give Call Renown Health Foundation at 775-982-5545 Mail a check to Renown Health Foundation, 1155 Mill St., O2, Reno, NV 89502 Venmo: @RenownFoundation     About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

Read More About A One-Year Reflection: Using the Art of Medicine to Heal Amidst a Pandemic

Renown Health has been working with the Washoe County Health District, the state, and the CDC to distribute the limited supplies of COVID-19 vaccines. Renown has completed more than 64,000 dose 1 and dose 2 vaccinations to date, which includes all of Tier 1A (Medical Staff members, Renown employees, students and volunteers) and eligible community members – which now includes everyone 16+.  “Renown is excited to continue along our goal of providing the opportunity for everyone who is interested in receiving the vaccine to be vaccinated at no charge,” said Tony Slonim, MD, DrPH, President and CEO of Renown Health. “We would like local businesses to know we have thousands of open appointments in early May and we encourage our business colleagues to share this information with employees so they may easily schedule an appointment through MyChart and continue on the path to a healthier and safer northern Nevada.”  “Renown is excited to continue along our goal of providing the opportunity for everyone who is interested in receiving the vaccine to be vaccinated at no charge,” said Tony Slonim, MD, DrPH, President and CEO of Renown Health. “We would like local businesses to know we have thousands of open appointments in early May and we encourage our business colleagues to share this information with employees so they may easily schedule an appointment through MyChart and continue on the path to a healthier and safer northern Nevada.”  Vaccine appointments for 18+ Anyone ages 18 and older may register for a free Renown Epic MyChart account. They do not need to have a Renown provider to enroll. With a MyChart account, they will be able to login and schedule their first vaccine appointment. These vaccines require two doses. After the first dose of the vaccine is documented in your MyChart account, you will get a notice to schedule your second dose. There are two easy ways to sign up for MyChart. Please see instructions in both English and Spanish. To schedule an appointment for a 16 or 17 year old: We have made special arrangements for minors ages 16 and 17. Please fill out this form, also found on https://covid.renown.org/vaccine/. Renown's Customer Engagement team will call the listed phone number within 14 business days to schedule the appointment. We appreciate your patience during this time as demand is high. Please note that a parent or guardian must accompany the teen when getting their vaccination. You are advised NOT to receive the vaccine if you: Are ill at the time of vaccination (fever, shortness of breath, vomiting, diarrhea or acute illness). Have been diagnosed with COVID-19 in the previous 14 days. Have received any other vaccination in the last 14 days. Have a history of significant allergic reaction to this vaccine or any of its ingredients. “Hometown Health is proud to be part of an organization offering COVID-19 vaccines to our community at no cost,” said David Hansen, CEO, Hometown Health. “The business community in northern Nevada is an important piece of the vaccination puzzle, and as a community-focused organization, we are pleased that Renown can safely offer vaccinations to local businesses and contribute to an increased hope for the future.”  Renown will provide additional updates on our websites at covid.renown.org. Please see b-roll, photos and fly-over footage of our Drive-Thru COVID-19 Vaccination Clinic here.     About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Clinical institutes include; Cancer, Heart and Vascular Heath and Neurosciences. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org

Read More About Businesses: Get Employees Vaccinated Against COVID-19 for Free

A coalition of 60 top hospitals and healthcare institutions have joined forces in a nationwide campaign to encourage adults to get vaccinated against COVID-19. Led by Cleveland Clinic and Mayo Clinic, the campaign "Get the Vaccine to Save Lives" is designed to reassure the public that vaccines are safe, effective and necessary to achieve herd immunity and return to normal activities. "We're asking people to talk to their healthcare providers if they have questions and then get vaccinated," says Gianrico Farrugia, M.D., Mayo Clinic's president and CEO. "The vaccine is our strongest asset to end the pandemic, and I urge everyone who is eligible to get whichever vaccine you're first offered to save lives." The campaign hopes to reach adults who are hesitant to receive a vaccine, including racial and minority ethnic groups and people living in rural communities. According to a Kaiser Family Foundation survey published March 30, 17% of the public say they will take a wait-and-see approach before getting it themselves, and another 20% say they will never get a vaccine or will only get it if required to do so for work, school or other activities. This leaves a significant portion of the population at risk of going unvaccinated.  The nationwide campaign includes print and digital advertising, media outreach, social media, an awareness video and an informational website. "The COVID-19 vaccine is safe and highly effective and offers our best hope for beating the disease," said Tom Mihaljevic, M.D., Cleveland Clinic's CEO and president. "We all want to see a return to our pre-COVID routines, when we can once again gather safely with family and friends. To reach that goal, we must improve vaccination rates to achieve herd immunity. Please sign up today because we are all in this together." With vaccine distribution underway, the campaign aims to help Americans feel safe and confident about receiving a vaccine. To achieve herd immunity and help end the pandemic, leading health officials say at least 75% of the population needs to receive a vaccine. Herd immunity occurs when a large portion of a community becomes immune to a disease, making the spread of disease from person to person unlikely. As a result, the whole community becomes protected — not just those who have been vaccinated. In addition to Mayo Clinic and Cleveland Clinic, 58 other leading U.S. healthcare institutions have joined the campaign. They include: Advent Health Adventist Health Allegheny Health Network Ann & Robert H. Lurie Children's Hospital of Chicago Arizona Medical Association Ascension St. Vincent's Atrium Health Banner Health Baptist Health South Florida Baylor Scott & White Health Beaumont Health BJC HealthCare Brooks Rehabilitation Broward Health Centura Health Einstein Healthcare Network Emory Healthcare Essentia Health Hackensack Meridian Honor Health Intermountain Healthcare    Lee Health Mass General Brigham McLaren St. Luke's MedStar Health Memorial Healthcare System Memorial Sloan Kettering Cancer Center Mercy Health Michigan Medicine Monument Health NCH Healthcare System Nicklaus Children's Health System North Shore University Health System Northwestern Medicine Norton Healthcare Peace Health Piedmont Healthcare ProMedica Renown Health Rush University Medical Center Chicago Southwestern Health Resources Spectrum Health Summit Health Texas Health          The Ohio State University Wexner Medical Center and The James Cancer Hospital The Toledo Clinic The University of Texas MD Anderson Cancer Center Theda Care UC Health (Cincinnati) UNC Health University Hospitals University of Chicago Medicine University of Iowa Health Care University of Toledo Medical Center UT Southwestern Medical Center Virtua Health Well Span Health Yale New Haven Health   More than 209 million doses of COVID-19 vaccine have been administered and 50% of the population age 18 and over has received at least one vaccine dose in the U.S. through April 18, according to the Centers for Disease Control and Prevention. COVID-19 vaccines were evaluated in tens of thousands of participants in clinical trials. The vaccines met the Food and Drug Administration's rigorous scientific standards for safety, effectiveness, and manufacturing quality needed to support emergency use authorization. Ethos Creative Group of Burlington, North Carolina, created the campaign and donated their services. Facebook, iHeartRadio, Spectrum Reach, The New York Times, The Washington Post, USA Today, and YouTube also provided complimentary resources. For more information about the campaign, visit ourshot2savelives.org     About Renown Health  Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Clinical institutes include: Cancer, Heart and Vascular Heath and Neurosciences. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

Read More About Leading U.S. Hospitals Team Up To Promote COVID-19 Vaccine

Physician researchers seek to understand how the immune system responds to COVID-19 and create a healthier Nevada. During the early stages of the pandemic, convalescent plasma was considered the only viable treatment option available for patients with COVID-19. Convalescent plasma is the component of the blood from recovered patients that may contain COVID-19 antibodies that help fight the infection. The National Institutes of Health has since developed treatment guidelines for COVID-19 based on clinical trial data and many studies are still underway worldwide assessing various additional treatment options. Convalescent plasma was in high demand but difficult to locate for COVID-19 patients in the northern Nevada area. A 24-year-old nursing assistant, Austin Meegan, was hospitalized and spent weeks staving off kidney and lung failure before learning he was eligible for an experimental blood transfusion that showed promise in treating COVID-19. Doctors estimated Meegan had only about a 3% chance of tracking down a donor to match his rare blood type. A COVID-19 survivor, Thomas Gibson, a Texas resident with the same blood type, traveled to Reno to donate his viral antibodies and a convalescent plasma donation credited with helping to save Meegan’s life. Physician clinical researchers and scientists at Renown and the University of Nevada, Reno School of Medicine (UNR Med) knew they needed to create better options for patients and physicians. Clinical researchers developed a study to help other patients like Austin, and pleaded for donations from recovered COVID-19 patients to donate their convalescent plasma. The researcher teams looked to understand how the body’s immune system responds to the virus over time, to aid them in developing new treatments for COVID-19. “The world’s capacity to get through the COVID crisis will depend on four things — science, technology, innovation and partnerships, says Tony Slonim, MD, DrPH, President and CEO of Renown Health.  “Taking lab bench discoveries to the bedside of patients in an efficacious and timely manner is not easy, but with UNR Med and our partners, we are making great strides in advancing clinical research which has the power to save lives and to create a healthier Nevada.” “It’s tremendously promising to partner on clinical research that will not only help us better understand the disease, but help inform treatment for those combatting COVID-19 that has had such a devastating impact on Nevadans, our nation and the world,” says UNR Med Dean Thomas L. Schwenk, MD. Renown, UNR Med and other area health care partners collaborated with Vitalant to collect plasma from recovered donors for a study on the treatment's efficacy. Eligible donors are at least 18 years old, weigh more than 110 pounds and are healthy. Donors had fully recovered from a confirmed diagnosis of COVID-19. Project coordinators at the Renown Research Office were overwhelmed by the community’s support and plasma blood donations. Additional partnerships with the Washoe County Health District, the State of Nevada and the Governor’s office, Saint Mary’s Medical Center, Northern Nevada Medical Center, Carson Tahoe Health and the VA Sierra Nevada Health Care System, along with many area health care providers helped the team meet their goals of enrolling 120 eligible participants in the study. “Our success in this study rests heavily on the support of our great community, as well as the innovation and collaboration demonstrated by Renown and UNR Med,” said Sara Healy, MD, MPH, principal investigator of the study and a pediatric infectious disease physician at Renown Children’s Hospital and UNR Med. “We are proud to be at the forefront of conducting essential research during such a pivotal time in history, and look forward to our continued partnership as we continue this important work.” “The control of COVID-19 in our communities relies on testing. The study that is being launched to develop a sensitive, specific and easier way to collect specimens (blood) is advancing the field and brings promise towards getting to our common goal of having the right diagnostic test for the right clinical situation at the right time,” says Mark Riddle, MD, DrPH, FISTM, associate investigator of the study and associate dean for clinical research and professor at UNR Med's Department of Internal Medicine and Medical Research. The research team is now asking area residents to participate in a study to analyze the efficacy of two COVID-19 tests. Participants will undergo two blood tests: one being a finger stick to provide results for a rapid test, and the other is a traditional venipuncture draw confirming the presence or absence of COVID-19 antibodies. This study is a collaboration with InBios International, Inc., a leading biotechnology company based in Seattle. Researchers are seeking: Individuals who have confirmed positive for COVID-19 and who have recently recovered from the virus. Study participants must be within 7-28 days from the onset of their symptoms. Individuals who have recently tested negative for COVID-19 and have never tested positive. Those who are interested in participating in the study may contact project coordinators at the Renown Research Office at (775) 982-3646, or via e-mail at covidplasmascreening@renown.org, 7:30 A.M. – 5:00 P.M., Monday through Friday. Individuals aged 18-75 in general good health are encouraged to consider participating in this ongoing study. There is no cost to participate in this study and participation is voluntary. An individual’s decision to participate will not affect their current or future relations with their health care provider(s), health district, or the community. Those who decide to participate are free to withdraw at any time. “Time is of the essence with COVID. If we can get test results to people and their clinicians in a more timely way, we can make a faster diagnosis of a patient's condition, says Christopher M. Kozlowski, MD, MHA, Renown's institutional research officer and Medical Director/VP of Renown Institute for Heart & Vascular Health. “As we refine the accuracy of our testing; we are applying sensitivity and specificity testing for true negative and true positive results. This provides people with more timely and accurate results and better quality care.”     About Renown Health Renown Health is a locally governed, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to improve the care and the health of our community.     About the University of Nevada, Reno School of Medicine The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Established in 1969, UNR Med is improving the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu.

Read More About Researchers at Renown Seek Convalescent Plasma Study Participants

Los hospitales de Renown se encuentran entre los primeros en el país en levantar las restricciones de visitantes para pacientes con COVID-19 y alentar a la familia a estar junto a la cama del paciente. El Dr. Dave y Darlene, verdaderos cazadores de tesoros, disfrutaban explorar tiendas de antigüedades y ventas de garaje para encontrar piezas antiguas dañadas o desechadas. Después de llevar el artículo a casa, Dave pasaba muchas horas raspándolo para limpiarlo, lijándolo y restaurándolo, hasta que relucía y se convertía en un mueble pulido, funcional y hermoso. Cada pieza de su hogar reaviva un recuerdo y tiene una historia que contar. El día de Acción de Gracias, cuando Dave estaba demasiado enfermo para reunirse alrededor de la mesa del comedor antiguo, Darlene llamó a la ambulancia. Dave había estado enfermo con COVID-19 durante dos semanas y no había mejorado. Cuando los técnicos de emergencias médicas llegaron a su casa y le preguntaron a Darlene qué condiciones preexistentes tenía, ella dijo, "todas". David estaba gravemente enfermo. Hospitalizado por COVID-19, sus opciones de comunicación eran limitadas. La única forma en que Darlene podía comunicarse con Dave era mediante una video llamada o por teléfono. Dave pasó 17 días hospitalizado en Renown Regional Medical Center en Reno. Darlene pasó 17 días esperando pegada al teléfono para obtener más información. Darlene dijo que tenía "días buenos y días malos", pero pensó que podría estar de regreso a casa, sentados en su mesa antigua para la cena de Navidad. David Ivan Randolph nació en Boston, Massachusetts el 29 de agosto de 1936. Creció en Roxbury y se graduó de la prestigiosa preparatoria Boston Latin Boys School. Obtuvo una licenciatura en psicología general, una maestría en Psicología experimental de la Universidad Northeastern y un doctorado en psicología y fisiología sensorial de la Universidad de Massachusetts, Amherst. Mientras estaba en la universidad, se unió al ROTC y al graduarse fue comisionado como Primer Teniente en el Cuerpo de Especialistas Médicos del Ejército. Después de una capacitación básica en la Escuela de Capacitación Médica de Fort Sam Houston, fue asignado como Capitán, Psicólogo de Investigación del Ejército de los EE. UU. División en Natick, Massachusetts. Durante los siguientes 30 años, realizó una investigación de la visión en Fort Knox, KY; Filadelfia, Pensilvania y luego con el recién construido Instituto de Investigación del Ejército Letterman (LAIR), División de Riesgos Oculares en el Presidio de San Francisco, CA. David continuó su investigación de la visión en LAIR hasta su jubilación en 1992 cuando el Presidio fue desmantelado. Los hallazgos de la investigación del Dr. Randolph sobre ceguera por destello y visión nocturna lo convirtieron en un presentador solicitado en conferencias de investigación en los Estados Unidos y en el extranjero. En un documental de PBS, fue entrevistado como parte del equipo que desarrolló unas gafas que protegen a los soldados del daño ocular del láser. El Dr. David Randolph perdió su batalla con COVID-19 el 13 de diciembre de 2020 y murió mientras dormía en una cama de hospital. Cuando Darlene escribió su obituario para el periódico, agradeció a las "excelentes enfermeras y médicos del Renown Regional Medical Center, por brindarle atención durante una época en que la familia no podía estar con él". Darlene deseó haber estado allí. Durante su matrimonio de 45 años, ella siempre había estado allí. Darlene dijo, "Siempre había estado junto a su cama, como su defensora, para ayudar a comunicar y aclarar las cosas". Como dietista registrada, trabajaba en hospitales y conocía el protocolo. Sabía que, al igual que los hospitales de todo el mundo, Renown había restringido las visitas de los miembros de la familia para detener la propagación del virus a otros pacientes, el personal y sus familiares. Aun así, deseaba haber pasado más tiempo con él. En Nochebuena, se sentó y le escribió al Dr. Anthony Slonim, presidente y director ejecutivo de Renown Health en Reno, Nevada. “Estimado doctor Slonim, como esposa de un paciente de COVID que falleció recientemente en su hospital, quiero expresarle mi agradecimiento a usted ya su personal por la atención que recibió en los últimos días de su vida. Estoy consciente que las enfermeras y el personal están trabajando en condiciones peligrosas y arriesgando su salud y sus vidas al atender a varios pacientes con COVID. El personal fue amable, se preocupó e hizo todo lo posible por mi esposo y por mí ". Ella continuó, "Sé que los procedimientos están cambiando cada hora para tratar de mantenerse a la vanguardia de este virus peligroso y estoy compartiendo mis experiencias con la esperanza de que sean útiles al establecer políticas que impacten a las familias". Darlene explicó que a pesar de recibir garantías de que la enfermera de Dave o incluso un médico llamarían a diario, a veces se olvidaban. Ella explicó en su carta, “lo importante que era, en estos tiempos en que la familia no puede visitar, y solo tienen comunicación ocasionalmente y están esperando ansiosamente en casa para saber de su ser querido, cuánto significa recibir una llamada de alguien quien cuidaba de él en el hospital ". Darlene pidió, "Si hay alguna forma en la que pueda ayudar a asegurar que las enfermeras tengan tiempo para hacer llamadas o ayudar a los pacientes a hacer llamadas, porque es una parte importante de la atención al paciente". Después de recibir su carta, el Dr. Slonim llamó a la Sra. David Randolph para agradecerle, ofrecerle sus condolencias y preguntarle si Renown podía ayudar de alguna manera. Darlene preguntó si podría reconsiderar permitir que las familias visiten a los pacientes del hospital que reciben tratamiento por COVID-19. El Dr. Slonim, quien también había perdido a su padre a causa del COVID-19 en abril en un hospital de Nueva Jersey, le pidió a su equipo de liderazgo que evaluara la solicitud de la Sra. Randolph e hiciera una recomendación. El equipo de liderazgo del hospital hizo una recomendación al Dr. Slonim que fue aprobada de inmediato. A medida que la situación del COVID-19 ha evolucionado, la política también lo ha hecho. Con un alto porcentaje del personal del hospital Renown ahora vacunado contra el COVID-19, disminuyendo las hospitalizaciones de pacientes con COVID-19 y entendiendo que las mejores comunicaciones son en persona, a partir del miércoles 27 de enero de 2021 por la mañana, los hospitales de Renown los consultorios médicos ahora fomentan el número limitado de visitantes para todos los pacientes, incluidos los diagnosticados con COVID-19. Renown continúa implementando medidas de seguridad adicionales para proteger la salud de los pacientes, visitantes y empleados de atención médica, y a medida que la situación cambia con el COVID-19, estas pautas están sujetas a cambios. "A partir de hoy, un Adulto de Apoyo para Pacientes sano puede acompañar a cada paciente a su visita médica o hospitalización de Renown", dijo Tony Slonim, MD, DrPH, presidente y director ejecutivo de Renown, "Vivimos según nuestros valores de empatía, integridad, colaboración y excelencia. Agradecemos a Darlene por recordarnos que la mejor atención es la 'atención centrada en la persona', un enfoque que abarca la perspectiva del paciente y sus seres queridos, al tiempo que promueve un entorno saludable y alentador para los cuidadores y aborda las necesidades de salud de nuestra comunidad. " “En Renown, la definición de" familia "la define el paciente", dice Debra Adornetto-García, DNP, RN, NEA-BC, AOCN, Directora de Enfermería de Servicios Agudos. “Nuestros pacientes pueden designar a cualquier persona que elijan como su Persona de Apoyo para Pacientes. La Persona de Apoyo para Pacientes es increíblemente importante y forma parte del equipo de atención. Se le pedirá a la Persona de Apoyo para Pacientes que se asocie con el equipo de atención médica del paciente para ayudar a comunicarse con otros familiares y amigos, participar en actividades de capacitación y educación y ayudar al paciente a cumplir con las instrucciones de atención y medicación ". “Cuando se trata de curación y recuperación, el papel de todos es importante”, enfatiza Paul Sierzenski, MD, MSHQS, CPE, FACEP, Director Médico de Servicios Agudos. “Lo que podemos hacer juntos para apoyar la atención del paciente y obtener excelentes resultados es más grande que lo que cualquiera de nosotros puede hacer solo. Esta creencia da forma a nuestro trabajo, nuestros servicios y la atención que brindamos a los pacientes, sus familias y amigos en Renown.” “Me complace que Renown Health haya modificado las políticas de visitas para que cada paciente pueda tener un visitante designado. Como ex paciente de la Unidad de Cuidados Intensivos y médico actual de la Unidad de Cuidados Intensivos, sé la importancia de contar con el apoyo de un ser querido en el hospital y estoy encantado de que podamos adaptarnos a este aspecto increíblemente importante de la atención al paciente”, dice Jacob B Keeperman, MD, FACEP, FAAEM, FAEMS, FCCM, Director Médico, Centro Regional de Transferencia y Operaciones de Renown, Intensivista. Cuando le dijeron a Darlene que su carta inspiró este cambio en las políticas de visitantes para pacientes con COVID-19, se mostró muy complacida y dijo, “Siempre he tratado de pensar en formas en las que podría ayudar a otras familias, especialmente a las parejas mayores donde uno está hospitalizado y el otro en casa. Mi deseo es ayudar a los demás ". De acuerdo con las pautas nacionales, a partir del 27 de enero de 2021, una Persona de Apoyo para Pacientes por paciente podrá acceder a Renown Regional Medical Center y Renown South Meadows Medical Center como se indica: El horario de visita para todos los pacientes, incluidos los diagnosticados con COVID-19, se extenderá de 8 am a 8 pm (antes era de 3 a 8 pm). Ahora se alienta a todos los pacientes a que designen hasta dos Personas de Apoyo para Pacientes. Debido a las limitaciones de espacio, pedimos que las Personas de Apoyo para Pacientes visiten uno a la vez). Los pacientes proporcionarán los nombres de hasta dos Personas de Apoyo para Pacientes durante la admisión/registración del paciente. Los nombres de las Personas de Apoyo para Pacientes se ingresarán en el registro médico electrónico del paciente para su privacidad y seguridad. El Renown Children’s Hospital/Hospital de Niños: Acceso abierto. (Se pueden designar dos padres y/o tutores como Personas de Apoyo para Pacientes, sin embargo, debido a las limitaciones de espacio actuales, le pedimos que visite uno a la vez). Para obtener información más detallada sobre el programa de Persona de Apoyo para Pacientes, visite https://www.renown.org/interact/     Acerca de Renown Health Renown Health es la red de atención médica integrada sin fines de lucro más grande de la región, de propiedad y administración local, que presta servicios a Nevada, Lake Tahoe y al noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de toda la vida. La organización está conformada de un centro de traumatología, dos hospitales de cuidados intensivos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencia, y la compañía de seguros sin fines de lucro local más grande de la región, Hometown Health. El modelo del instituto de Renown aborda los determinantes sociales de la salud e incluyen: Salud Infantil, Salud del Comportamiento y Adicciones, Envejecimiento Saludable e Innovación en Salud. Los institutos clínicos incluyen: Cáncer, Corazón y Salud Vascular y Neurociencias. Actualmente, Renown está inscribiendo a participantes en el estudio de salud de la población genética basada en la comunidad más grande del mundo, el Healthy Nevada Project®. Para obtener más información, visite https://www.renown.org/.

Read More About Voces De Cambio Viuda En Reno Inspira Una Nueva